Citations

Clear

4610 citation(s) found for "Lu, Brian".

Bow Hunter’s Syndrome Secondary to Dysmorphic C1 Lateral Mass Compressing Vertebral Artery: A Case of Acute and Subacute Stroke in a Pediatric Patient (P1-14.008)
Lee, Eun Hye , Appavu, Brian

Mayo Clinic

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000211031 Get It

Computed Tomography Perfusion Imaging Profiles Are Similar Before and After Transfer to a Comprehensive Stroke Center (P11-13.003)
Miller, Małgorzata , Abobaker, Esam, Wideman, Brian, Khan, Nadeem , Khan, Muhib, Reeves, Mathew J. , Khan, Nadeem I , Khan, Muhib , Oostema, J. Adam

Mayo Clinic

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000212331 Get It

Implementation of a rural severity-based EMS stroke destination protocol improves destination selection for EMS suspected strokes. (P9-13.017)
Miller, Małgorzata , Abobaker, Esam, Wideman, Brian, Khan, Nadeem , Khan, Muhib , Reeves, Mathew J. , Khan, Nadeem I , Oostema, J. Adam

Mayo Clinic

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000212297 Get It

Responsive Neurostimulation and Focal Cortical Dysplasia: Personalizing Technology to Pathology in Drug-Resistant Epilepsy (P5-9.003)
Chang, Vincent H.S. , Reeders, Puck C. , Chang, Vincent, Pati, Sandipan Bankim Behari , Lundstrom, Brian N. , Rao, Vikram R. , Agashe, Shruti

Mayo Clinic

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000208923 Get It

84-Year-Old Male with Kelch-like Protein 11 (KLHL11) Antibody-Associated Rhombencephalitis and Merkel Cell Carcinoma (P3-8.013)
Pascoe, Jasmine, Krulisky, Kathryn, Johnson, Brian , Galli, Jonathan , Mahoney, Kyle , Guo, Yong , Crane, Paul D. , Swaminathan, Priya, Pascoe, Jasmine, Jacobson, Matthew P. , Mahoney, Kyle, Dubey, Divyanshu , Crane, Paul

Mayo Clinic

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000208623 Get It

Compass rose for generating community–based referrals: Best practices and lessons learned
Westfall, Erin , Sosso, Jessica , Harper, Sarah, Bishop, Alyssa, Canan, Liz, Chaudhry, Rajeev , Davis, M. R. , Mackinson, Brian, Marfilius, Traci, Mauerman, Gretchen, Zuehlke, Karen, Paul, Maggie, Westfall, Erin , Harper, Sarah, Bishop, Alyssa, Davis, Marquita, Paul, Maggie

Mayo Clinic

Health Services Research | April 7, 2025 | Volume: 60 | Issue: S1 | Pages: No page available

10.1111/1475-6773.14587 Get It

Influence of body mass index on cardiovascular risk in rheumatoid arthritis varies across anti-citrullinated protein antibody status and biologic use
Karpouzas, George , González‐Gay, Miguel Á. , Corrales, Alfonso, Myasoedova, Elena , Rantapää‐Dahlqvist, Solbritt , Sfikakis, Petros P. , Dessein, PH, Pascual‐Ramos, Virginia , Contreras-Yáñez, Irazú , Galarza-Delgado, D. Á. , Riel, Piet Leonardus Cornelis Maria van, Patrick, D R, Løgstrup, Brian Bridal , Hauge, Ellen‐Margrethe , Karpouzas, George Athanasios , Dessein, Patrick , Pascual-Ramos, Virginia , Colunga-Pedraza, Iris J , Galarza-Delgado, Dionicio Angel , Semb, Anne Grete , Misra, Durga Prasanna , Gonzalez-Gay, Miguel A , Myasoedova, Elena , Rantapää-Dahlqvist, Solbritt , Hitchon, Carol , Colunga-Pedraza, I. J. , Azpiri-Lopez, Jose Ramon , Semb, Anne Grete , Riel, Piet L. C. M. van , Misra, Durga Prasanna , Kitas, George D. , Ormseth, Sarah R.

Mayo Clinic

RMD Open | April 5, 2025 | Volume: 11 | Issue: 2 | Pages: e005464

10.1136/rmdopen-2025-005464 | PMID 40187772 Get It

Objectives The impact of body mass index (BMI) on cardiovascular risk in rheumatoid arthritis (RA) is unclear. RA characteristics may influence the association between BMI and risk. Disease activity, which predicts cardiovascular risk, is associated with obesity only among anticitrullinated antibody (ACPA)-positive patients. Biologics alter body composition and mitigate cardiovascular risk in RA. We explored the association of BMI with cardiovascular risk and whether this varied across ACPA status and biologic use. Methods We evaluated 3982 patients from an international observational cohort. Outcomes included (a) first major adverse cardiovascular event (MACE) encompassing myocardial infarction, stroke or cardiovascular death; and (b) all events comprising MACE, angina, revascularisation, transient ischaemic attack, peripheral arterial disease and heart failure. Multivariable Cox models stratified by centre risk evaluated the impact of BMI, ACPA, biologics and their two- and three-way interactions on outcomes. Results We recorded 192 MACE and 319 total events. No main effects of BMI, ACPA or biologics were observed. A three-way interaction between them on MACE (p-interaction<0.001) and all events (p-interaction=0.028) was noted. Among ACPA negative patients, BMI was inversely associated with MACE (HR 0.38 (95% CI 0.25 to 0.57)) and all events (HR 0.67 (0.49 to 0.92)) in biologic users but not non-users (p-for-interaction <0.001 and 0.012). Among ACPA-positive patients, BMI was associated with MACE (HR 1.04 [1.01–1.07]) and all events (HR 1.03 (1.00 to 1.06)) independently of biologic use. Conclusions BMI is inversely associated with cardiovascular risk only among ACPA-negative biologic users. In contrast, BMI is associated with cardiovascular risk in ACPA-positive patients independently of biologic use.
Evaluation of AI Summaries on Interdisciplinary Understanding of Ophthalmology Notes
Becerra, Clara M. Castillejo , Dahl, Heidi M., Patel, Neil R. , Kaplan, Tyler M., Kohli, Darrell, Bothun, Erick D. , Mohney, Brian G., Tooley, Andrea A. , Baratz, Keith H. , Iezzi, Raymond , Bakri, Sophie J. , Roddy, Gavin W. , Hodge, David O. , Sit, Arthur J. , Chen, John J. , D'Souza, Haley S, Barkmeier, Andrew J. , Hodge, David, Chen, John J , Castillejo Becerra, Clara M , Sit, Arthur J , Tailor, Prashant D. , D’Souza, Haley S. , Patel, Neil R., Starr, Matthew R.

Mayo Clinic

JAMA Ophthalmology | April 4, 2025 | Volume: 143 | Issue: 5 | Pages: 410

10.1001/jamaophthalmol.2025.0351 | PMID 40178837 Get It

ImportanceSpecialized ophthalmology terminology limits comprehension for nonophthalmology clinicians and professionals, hindering interdisciplinary communication and patient care. The clinical implementation of large language models (LLMs) into practice has to date been relatively unexplored.ObjectiveTo evaluate LLM–generated plain language summaries (PLSs) integrated into standard ophthalmology notes (SONs) in improving diagnostic understanding, satisfaction, and clarity.Design, Setting, and ParticipantsRandomized quality improvement study conducted from February 1, 2024, to May 31, 2024, including data from inpatient and outpatient encounters in a single tertiary academic center. Participants were nonophthalmology clinicians and professionals and ophthalmologists. The single inclusion criterion was any encounter note generated by an ophthalmologist during the study dates. Exclusion criteria were (1) lack of established nonophthalmology clinicians and professionals for outpatient encounters and (2) procedure-only patient encounters.InterventionAddition of LLM-generated plain language summaries to ophthalmology notes.Main Outcomes and MeasuresThe primary outcome was survey responses from nonophthalmology clinicians and professionals assessing understanding, satisfaction, and clarity of ophthalmology notes. Secondary outcomes were survey responses from ophthalmologists evaluating PLS in terms of clinical workflow and accuracy, objective measures of semantic quality, and safety analysis.ResultsA total of 362 (85%) nonophthalmology clinicians and professionals (33.0% response rate) preferred the PLS to SON. Demographic data on age, race and ethnicity, and sex were not collected. Nonophthalmology clinicians and professionals reported enhanced diagnostic understanding (percentage point increase, 9.0; 95% CI, 0.3-18.2; P = .01), increased note detail satisfaction (percentage point increase, 21.5; 95% CI, 11.4-31.5; P &amp;lt; .001), and improved explanation clarity (percentage point increase, 23.0; 95% CI, 12.0-33.1; P &amp;lt; .001) for notes containing a PLS. The addition of a PLS was associated with reduced comprehension gaps between clinicians who were comfortable and uncomfortable with ophthalmology terminology (from 26.1% [95% CI, 13.7%-38.6%; P &amp;lt; .001] to 14.4% [95% CI, 4.3%-24.6%; P &amp;gt; .06]). PLS semantic analysis found high meaning preservation (bidirectional encoder representations from transformers score mean F1 score: 0.85) with greater readability than SONs (Flesch Reading Ease: 51.8 vs 43.6; Flesch-Kincaid Grade Level: 10.7 vs 11.9). Ophthalmologists (n = 489; 84% response rate) reported high PLS accuracy (90% [320 of 355] a great deal) with minimal review time burden (94.9% [464 of 489] ≤1 minute). PLS error rate on ophthalmologist review was 26% (126 of 489). A total of 83.9% (104 of 126) of errors were deemed low risk for harm and none had a risk of severe harm or death.Conclusions and RelevanceIn this study, use of LLM-generated PLSs was associated with enhanced comprehension and satisfaction among nonophthalmology clinicians and professionals, which might aid interdisciplinary communication. Careful implementation and safety monitoring are recommended for clinical integration given the persistence of errors despite physician review.
Risk of cardiovascular disease in people with narcolepsy: a plain language summary of publication
Black, Jed , Smith, R. Brian, Dabrowski, Elizabeth , Taylor, Ben , Somers, Virend K.

Mayo Clinic

Future Cardiology | April 3, 2025 | Volume: 21 | Issue: 6 | Pages: 339-348

10.1080/14796678.2025.2482383 | PMID 40176411 Get It